Michael Brenner is currently an advisor at Scailyte. Michael was previously employed at Roche Pharmaceuticals from February 2007 to December 2014, where they were the Leader of Clinical Protein Biomarkers & CVM Functional Representative. Michael has extensive experience in the pharmaceutical industry, and their expertise will be invaluable to Scailyte.
Michael Brenner has a Diplomate of the American Board of Toxicology (D.A.B.T.), a Ph.D. in Immunology, and a D.E.A. in Molecular and Cellular Biology and Genetics, Biotechnologies from Université Paul Sabatier Toulouse III. Michael also has an M.Sc.Eng. in Biotechnical and Food Engineering from Institut national des Sciences appliquées de Toulouse. Michael is certified in Pricing Strategy: Value-Based Pricing from LinkedIn and in DABT from the American Board of Toxicology, Inc.
This person is not in the org chart